These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 23651229)

  • 1. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
    Liu J; Cao W; Chen W; Xu L; Zhang C
    J Oral Pathol Med; 2015 Feb; 44(2):109-14. PubMed ID: 25060050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma.
    Liu S; Ye D; Wang T; Guo W; Song H; Liao Y; Xu D; Zhu H; Zhang Z; Deng J
    Cancer Cell Int; 2017; 17():34. PubMed ID: 28270740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Cathepsin B in oral squamous cell carcinoma.
    Yang X; Wei KJ; Zhang L; Pan HY; Li J; Chen WT; Zhong LP; Zhang ZY
    Int J Oral Maxillofac Surg; 2010 Feb; 39(2):174-81. PubMed ID: 20042316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
    Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
    Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
    Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
    Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
    J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear and cytoplasmic expression of Met in oral squamous cell carcinoma and in an organotypic oral cancer model.
    Brusevold IJ; Søland TM; Khuu C; Christoffersen T; Bryne M
    Eur J Oral Sci; 2010 Aug; 118(4):342-9. PubMed ID: 20662906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
    Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
    Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.